Medicare Payment Levels For Lab Technologies Criticized At IoM Meeting
This article was originally published in The Gray Sheet
Executive Summary
The Health Care Financing Administration needs to adopt principled methodologies for "gap-filling" and "cross-walking" in assigning pricing codes to new lab technologies in order to establish appropriate Medicare payment levels for new lab diagnostics, industry groups commented during an Institute of Medicine public meeting Jan. 20 in Washington, D.C.
You may also be interested in...
ICD-10: Medicare Inpatient Billing System Divides AMA, Manufacturers
HCFA's ICD-10 procedural coding system is too complex to be adopted in its current form, the American Medical Association recommends in contrast to AdvaMed, which seeks "rapid" implementation of the system to replace ICD-9-CM.
ICD-10: Medicare Inpatient Billing System Divides AMA, Manufacturers
HCFA's ICD-10 procedural coding system is too complex to be adopted in its current form, the American Medical Association recommends in contrast to AdvaMed, which seeks "rapid" implementation of the system to replace ICD-9-CM.
HCFA Clinical Lab Test Payments Should Defer To NLA Levels, IoM Says
Medicare outpatient clinical laboratory payments should be set at the current national limitation amounts (NLAs), pending development of a resource-based relative value scale, the Institute of Medicine advises in a recent report.